Kbc Group Nv Arrowhead Pharmaceuticals, Inc. Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 4,749 shares of ARWR stock, worth $182,694. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,749

Previous 7,356 35.44%

Holding current value

$182,694

Previous $94,000 20.21%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$9.99 - $16.97 $26,043 - $44,240	-2,607 Reduced 35.44%	4,749 $75,000
Q1 2025 Apr 25, 2025	BUY	$12.74 - $21.53 $27,161 - $45,901	2,132 Added 40.81%	7,356 $94,000
Q4 2024 Jan 22, 2025	BUY	$17.7 - $26.34 $29,098 - $43,302	1,644 Added 45.92%	5,224 $98,000
Q2 2024 Jul 17, 2024	BUY	$21.87 - $28.24 $18,261 - $23,580	835 Added 30.42%	3,580 $93,000
Q1 2024 May 08, 2024	BUY	$27.21 - $39.48 $12,788 - $18,555	470 Added 20.66%	2,745 $79,000
Q4 2023 Feb 13, 2024	BUY	$21.2 - $31.03 $29,044 - $42,511	1,370 Added 151.38%	2,275 $70,000
Q3 2023 Feb 15, 2024	BUY	$26.2 - $36.08 $35,894 - $49,429	1,370 Added 151.38%	2,275 $61,000
Q2 2023 Feb 15, 2024	SELL	$25.16 - $41.38 $34,469 - $56,690	-1,370 Reduced 60.22%	905 $32,000
Q2 2023 Jul 28, 2023	BUY	$25.16 - $41.38 $22,769 - $37,448	905 New	905 $32,000
Q1 2023 Feb 14, 2024	BUY	$23.68 - $38.51 $6,796 - $11,052	287 Added 46.44%	905 $23,000
Q4 2022 Feb 14, 2024	SELL	$28.0 - $40.56 $44,072 - $63,841	-1,574 Reduced 71.81%	618 $25,000
Q2 2022 Jul 26, 2022	SELL	$27.79 - $50.61 $60,915 - $110,937	-2,192 Closed	0 $0
Q1 2022 Feb 14, 2024	SELL	$39.62 - $69.97 $3,288 - $5,807	-83 Reduced 3.65%	2,192 $101,000
Q1 2022 May 06, 2022	BUY	$39.62 - $69.97 $86,847 - $153,374	2,192 New	2,192 $101,000
Q4 2021 Feb 03, 2022	SELL	$58.09 - $82.51 $154,228 - $219,064	-2,655 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$43.82 - $85.37 $70,550 - $137,445	-1,610 Reduced 37.75%	2,655 $204,000
Q3 2020 Oct 28, 2020	BUY	$33.21 - $51.27 $134,998 - $208,412	4,065 Added 2032.5%	4,265 $184,000
Q2 2020 Aug 10, 2020	BUY	$26.12 - $43.27 $5,224 - $8,654	200 New	200 $9,000

Others Institutions Holding ARWR

# of Institutions

324

Shares Held

99.5M

Call Options Held

444K

Put Options Held

568K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account